Filtered,not unfiltered,coffee in cardiovascular disease

Freedman ND Park Y Abnet CC , et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; 366: 1891–1904.

Saito E Inoue M Sawada N , et al. Association of coffee intake with total and cause-specific mortality in a Japanese population: The Japan Public Health Center-based Prospective Study. Am J Clin Nutr 2015; 101: 1029–1037.

Ding M Satija A Bhupathiraju SN , et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation 2015; 132: 2305–2315.

Grosso G Micek A Godos J , et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: A dose-response meta-analysis. Eur J Epidemiol 2016; 31: 1191–1205.

Park SY Freedman ND Haiman CA , et al. Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med 2017; 167: 228–235.

Nohara-Shitama Y Adachi H Enomoto M , et al. Habitual coffee intake reduces all-cause mortality by decreasing heart rate. Heart Vessels 2019; 34: 1823–1829.

Tverdal A Selmer R Cohen JM , et al. Coffee consumption and mortality from cardiovascular diseases and total mortality. Does the brewing method matter? Eur J Prev Cardiol 2020; 27: 1986–1993.

Echeverri D Montes FR Cabrera M , et al. Caffeine’s vascular mechanisms of action. Int J Vasc Med 2010; 2010: 834060.

Keijzers GB De Galan BE Tack CJ , et al. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 2002; 25: 364–369.

Hino A Adachi H Enomoto M , et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: An epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007; 76: 383–389.

Yeh TC Liu CP Cheng WH , et al. Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling. Hypertension 2014; 63: 535–541.

Krittanawong C Tunhasiriwet A Wang Z , et al. Is caffeine or coffee consumption a risk for new-onset atrial fibrillation? A systematic review and meta-analysis. Eur J Prev Cardiol 2020. Epub ahead of print 18 March 2020. DOI: 10.1177/2047487320908385.

Casiglia E Tikhonoff V Albertini F , et al. Caffeine intake reduces incident atrial fibrillation at a population level. Eur J Prev Cardiol 2018; 25: 1055–1062.

Bazal P Gea A Navarro AM , et al. Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts. Eur J Prev Cardiol 2020. Epub ahead of print 4 March 2020. DOI: 10.1177/2047487320909065.

Bigotte Vieira M Magrico R Viegas Dias C , et al. Caffeine consumption and mortality in chronic kidney disease: A nationally representative analysis. Nephrol Dial Transplant 2019; 34: 974–980.

Kannel WB Kannel C Paffenbarger RS Jr , et al. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113: 1489–1494.

Shigetoh Y Adachi H Yamagishi S , et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22: 151–155.